Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Psychiatric Association (1994) Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 151:( Suppl. Dec ): 1–36
Apter JT, Woolfolk RL (1990) Lithium augmentation of bupropion in refractory depression. Ann Clin Psychiatry 2: 7–10
Bauer M (1995) The combined use of lithium and SSRIs. J Serotonin Res 2: 69–76
Bauer M, Ahrens B (1996) Bipolar disorder: A practical guide to drug treatment. CNS Drugs 6 (1): 35–52
Bauer M, Döpfmer S. Lithiumaugmentation in refractory depression: Meta-analysis of placebo-controlled studies. Manuskript in Vorbereitung
Bauer M, Kunz D, Ströhle A, Müller-Oerlinghausen B (1995) What is the optimal duration of lithiumaugmentation in refractory depression? Preliminary results from a controlled trial. Pharmacopsychiatry 26: 163 (Abstract)
Bauer M, Linden M, Schaaf B, Weber HJ (1996) Adverse events and tolerability of the combina- tion of fluoxetine/lithium compared with fluoxetine. J Clin Psychopharmacol 16: 130–134
Baxter LR, Liston EH, Schwartz JM, Altshuler LL, Wilkins JN, Richeimer S, Guze BH (1986) Prolongation of the antidepressant response to partial sleep deprivation by lithium. Psychiatry Res 19: 17–23
Blier P, de Montigny C, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 7: 24–35
Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W (1995) Drug interactions in psychiatry. Williams & Wilkins, Baltimore
Cournoyer G, de Montigny C, Ouellette J, Leblanc G, Langlois R, Elie R (1984) Lithium addition in tricyclic-resistant unipolar depression: a placebo-controlled study. Abstracts of Collegium Internationale Neuropsychopharmacologicum, Florence, Italy, June 19–23, p. 179
Cowen PJ, McCance SL, Ware CJ, Cohen PR, Chalmers JS, Julier DL (1991) Lithium in tricyclic-resistant depression. Br J Psychiatry 159: 341–346
Dallai A, Fontaine R, Ontiveros A, Elie R (1990) Lithium carbonate augmentation of desipramine in refractory depression. Can J Psychiatry 35: 608–611
Devanand DP, Sackeim HA, Brown RP (1988) Myoclonus during combined tricyclic antidepressant and lithium treatment. J Clin Psychopharmacol 8: 446–447
Dinan TG (1993) Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study. Acta Psychiatr Scand 88: 300–301
Dinan TG, Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 80: 97–100
Evans M, Marwick P (1990) Fluvoxamine and lithium: an unusual interaction. Br J Psychiatry 156: 286 (letter)
Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM (1994) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study. Am J Psychiatry 151: 1372–1374
Fein S, Paz V, Rao N, LaGrassa J (1988) The combination of lithium carbonate and a MAOI in refractory depressions. Am J Psychiatry 145: 249–250
Finch EJL, Katona CLE (1989) Lithium augmentation in the treatment of refractory depression in old age. Int J Geriatric Psychiatry 4: 41–46
Flint A (1992) Lithium augmentation in antidepressant-resistant patients. Br J Psychiatry 160: 710
Flint AJ, Rifat SL (1994) A prospective study of lithium augmentation in antidepressant-resistant geriatric depression. J Clin Psychopharmacol 14: 353–356
Garbutt JC, Mayo JP, Gilette GM, Little KY, Mason GA (1986) Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation. Am J Psychiatry 143: 1038–1039
Ghadirian AM, Kusalic M (1990) Rapid cycling following antidepressant in an adolescent. Biol Psychiatry 27: 1183–1184
Goodwin FK, Jamison KR (1990) Manic-depressive illness. Oxford University Press, Oxford
Hawley CJ, Roberts AG, Baldwin DS (1994b) Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions. Int Clin Psychopharmacol 9: 31–33
Hawley CJ, Roberts AG, Walker MH (1994a) Tolerability of combined treatment with lithium and paroxetine: 19 cases treated under open conditions. J Psychopharmacol 8: 266–267
Heninger GR, Charney DS, Sternberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Arch Gen Psychiatry 40: 1335–1342
Hoencamp E, Haffmans PMJ, Dijken WA, Hoogduin CAL, Nolen WA, van Dyck R (1994) Brofaromine versus lithium addition to maprotiline. A double-blind study in maprotiline refractory depressed outpatients. J Affect Disorders 30: 219–227
Joffe RT, Levitt AJ, Bagby RM, MacDonald C, Singer W (1993a) Predictors of response to lithium and triiodothyronine augmentation of antidepressants in tricyclic non-responders. Br J Psychiatry 163: 574–578
Joffe RT, Singer W, Levitt AJ, MacDonald C (1993b) A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry 50: 387–393
Johnson FN (1991) Lithium augmentation therapy in depression. In: Johnson S, Johnson FN (eds) Reviews in Contemporary Pharmacotherapy, Vol 2, No 1, Marius Press, pp. 3–52
Kantor D, McNevin S, Leichner P, Harper D, Krenn M (1986) The benefit of lithium carbonate adjunct in refractory depression–fact or fiction? Can J Psychiatry 31: 416–418
Katona CLE (1988) Lithium augmentation in refractory depression. Psychiatr Dev 2: 153–171
Katona CLE, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, Burns RA, Robertson MM (1995) Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 166: 80–86
Katona CLE, Finch EJL (1991) Lithium augmentation for refractory depression in old age. In: Amsterdam JD (ed) Advances in Neuropsychiatry and Psychopharmacology, Vol 2: Refractory Depression. Raven Press, New York, pp 177–184
Kushnir SL (1986) Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. Am J Psychiatry 143: 378–379
Louie AK, Meltzer HY (1984) Lithium potentiation of antidepressant treatment. J Clin Psychopharmacol 4: 316–321
Mendels J (1976) Lithium in the treatment of depression. Am J Psychiatry 133 (4): 373–378
Montigny de C (1994) Lithium addition in refractory depression. In: Nolen WA, Zohar J, Roose SP, Amsterdam JD (eds) Refractory depression: Current strategies and future directions, John Wiley & Sons, Chichester, pp 47–57
Montigny de C, Aghajanian GK (1978) Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 202: 1303–1306
Montigny de C, Cournoyer G, Morissette R (1983) Lithium carbonate addition in tricyclic antidepressant resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drug and lithium action on the serotonin system. Arch Gen Psychiatry 40: 1327–1334
Montigny de C, Elie R, Caille G (1985) Rapid response to the addition of lithium in iprindoleresistant unipolar depression: a pilot study. Am J Psychiatry 142: 220–223
Montigny de C, Grunberg F, Mayer A, Deschenes JP (1981) Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry 138: 252–256
Muly EC, McDonald W, Steffens D (1993) Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry 150: 1565 (letter)
Noveske FG, Hahn KR, Flynn RJ (1989) Possible toxicity of combined fluoxetine and lithium. Am J Psychiatry 146: 1515 (letter)
Ontiveros A, Fontaine R, Elie R (1991) Refractory depression: the addition of lithium to fluoxetine or desipramine. Acta Psychiatr Scand 83: 188–192
Pai MA, White AC, Deane AG (1986) Lithium augmentation in the treatment of delusional depression. Br J Psychiatry 148: 736–738
Peet M (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 164: 549–550
Pope HG, McElroy SL, Nixon RA (1988) Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatry 145: 1292–1294
Price LH (1989) What is the duration for augmentation with T3 or lithium in resistant depression? J Clin Psychopharmacol 9: 73
Price LH, Charney DS, Heninger GR (1984) Manic symptoms following addition of lithium to antidepressant treatment. J Clin Psychopharmacol 4: 361–362
Price LH, Charney DS, Heninger GR (1986) Variability of response to lithium augmentation in refractory depression. Am J Psychiatry 143: 1387–1392
Price LH, Conwell Y, Nelson JC (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatry 140: 318–322
Schöpf J (1989) Lithiumzugabe zu Thymoleptika als Behandlung therapieresistenter Depressionen. Nervenarzt 60: 200–205
Schöpf J, Baumann P, Lemarchand T, Rey M (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry 22: 183–187
Schou M (1990) Lithium and treatment-resistant depressions: a review. Lithium 1: 38
Schou M (1995) Prophylactic lithium treatment of unipolar and bipolar manic-depressive illness. Psychopathology 28 (Suppl.): 81–85
Souza FGM, Goodwin GM (1991) Lithium treatment and prophylaxis in unipolar depression: A meta-analysis. Br J Psychiatry 158: 666–675
Stein G, Bernadt M (1993) Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Br J Psychiatry 162: 634–640
Sternbach H (1991) The serotonin syndrome. Am J Psychiatry 148: 705–713
Terao T, Yoshimura R, Abe K (1990) Lithium potentiation of tetracyclic antidepressants. Biol Psychiatry 28: 1065–1080
Thase ME, Kupfer DJ, Frank E, Jarrett DB (1989) Treatment of imipramine-resistant recurrent depression: II. an open clinical trial of lithium augmentation. J Clin Psychiatry 50: 413–417
Yuvarajan R, Yousufzai NM (1988) Mania induced by lithium augmentation. Br J Psychiatry 153: 828–830
Zimmer B, Rosen J, Thornton JE, Perel JM, Reynolds CF (1991) Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients. J Clin Psychopharmacol n: 254–256
Zusky PM, Biederman J, Rosenbaum JF, Manschreck TC, Gross CC, Weilberg JB, Gastfriend DR (1988) Adjunct low dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. J Clin Psychopharmacol 8: 120–124
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bauer, M. (1997). Lithiumaugmentation. In: Bauer, M., Berghöfer, A. (eds) Therapieresistente Depressionen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10500-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-10500-9_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-61675-7
Online ISBN: 978-3-662-10500-9
eBook Packages: Springer Book Archive